Leukocytoclastic vasculitis

被引:0
|
作者
Sunderkötter, C
Roth, J
Bonsmann, G
机构
[1] Univ Ulm Klinikum, Univ Klin & Poliklin Dermatol & Allergol, D-89081 Ulm, Germany
[2] Univ Klinikum Munster, Inst Expt Dermatol, Munster, Germany
[3] Univ Klinikum Munster, Univ Kinderklin, Munster, Germany
[4] Univ Klinikum Munster, Klin & Poliklin Hautkrankheiten, Munster, Germany
来源
HAUTARZT | 2004年 / 55卷 / 08期
关键词
leukocytoclastic vasculitis; purpura; immune complex; Henoch-Schonlein purpura; hypersensitivity vasculitis; ANCA;
D O I
10.1007/s00105-004-0760-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Leukocytoclastic vasculitis (LcV) is the most common form of cutaneous vasculitis. Often LcV results from deposition of immune complexes in the vascular wall. When IgA is the dominant immunoglobulin in these complexes, systemic involvement is likely (Henoch-Schonlein purpura), being more severe in adults. LcV in which immune complexes are composed of IgG or IgM are more often limited to the skin and may additionally show minor systemic involvement. in other forms of LcV additional pathophysiological factors play a role. LcV can also be a presenting or accompanying symptom of severe systemic ANCA-associated vasculitis. in some cases, LcV is a sign of bacteriemia. The aim of diagnostic procedures is to determine the specific type of vasculitis and degree of systemic involvement as well as possible causes. If no trigger or cause can be found, uncomplicated cases of LcV should be treated symptomatically. Corticosteroids are indicated at initial signs of necrosis or ulceration. Chronic recurrent LcV may respond to dapsone or colchicine. Severe systemic vasculitis requires immunosuppressive therapy.
引用
下载
收藏
页码:759 / 783
页数:25
相关论文
共 50 条
  • [21] Dabigatran Associated Leukocytoclastic Vasculitis
    Potolidis, Evangelos
    Mandros, Charalampos
    Kotsa, Kalliopi
    Mitsiou, Evdoxia
    Potolidis, Dimitris
    Fanourgiakis, Panagiotis
    CASE REPORTS IN MEDICINE, 2015, 2015
  • [22] CASE FOR DIAGNOSIS - LEUKOCYTOCLASTIC VASCULITIS
    WELLS, GC
    WOODS, B
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1973, 66 (05): : 438 - 449
  • [23] Leukocytoclastic Vasculitis: A Case Report
    Malik, Mona J.
    Pasha, Muhammad Nabeel
    Salib, Victor
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [24] LEUKOCYTOCLASTIC VASCULITIS IN THE BONE MARROW
    Sari, Alper
    Armagan, Berkan
    Erden, Abdulsamet
    Kilic, Levent
    Ayhan, Arzu Saglam
    Karadag, Omer
    RHEUMATOLOGY, 2017, 56 : 72 - 72
  • [25] Leukocytoclastic vasculitis induced by lercanidipine
    Zgolli, F.
    Aouinti, I.
    Lakhoua, G.
    Charfi, O.
    Ben-Hammamia, S.
    El-Aidli, S.
    Daghfous, R.
    Zaiem, A.
    Kastalli, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 75 - 75
  • [26] Syphilis showing leukocytoclastic vasculitis
    Kim, Dong Hyun
    Choi, Se Rim
    Lee, Kyung Real
    Yoon, Moon Soo
    JOURNAL OF CUTANEOUS PATHOLOGY, 2010, 37 (05) : 607 - 608
  • [27] Apixaban Causing Leukocytoclastic Vasculitis
    Bin Nasir, Usama
    Kumar, Aswini
    Easwar, Arti
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1744 - 1745
  • [28] Leukocytoclastic vasculitis caused by iodixanol
    Paula, V.
    Dalmau, G.
    Valor, B.
    Skrabski, F.
    Badia, C.
    Gazquez, V.
    ALLERGY, 2023, 78
  • [29] Diagnosis and management of leukocytoclastic vasculitis
    Paolo Fraticelli
    Devis Benfaremo
    Armando Gabrielli
    Internal and Emergency Medicine, 2021, 16 : 831 - 841
  • [30] Anticardiolipin antibodies in leukocytoclastic vasculitis
    Sais, G
    Vidaller, A
    Peyri, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (05) : 805 - 806